Medical device recalls Moderate risk

Roche Diagnostics Corporation recalls Lactate Gen.2, Catalog Nos. 03183700190, 05171881190, 11822837190, ***added as of 5/10/19*** 03183700190 Product Usage:…

Recall date
December 17, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1146-2019
FDA classification
Class II
Brand / firm
Roche Diagnostics Corporation
Sold / distributed
US Nationwide distribution.

Why it was recalled

New endogenous interference claims have been established for the following assays used on the cobas c 311 analyzer and the cobas c 501, 502, 701, 702, and Modular Analytics P/D modules which may have potential medical risk. ***Update: Cobas c111 and COBAS INTEGRA 400 plus analyzers are also impacted for BILT3 and LACT2 assays***

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lactate Gen.2, Catalog Nos. 03183700190, 05171881190, 11822837190, ***added as of 5/10/19*** 03183700190 Product Usage: An In vitro diagnostic reagent system intended for use on cobas Integra for the quantitative determination of the lactate concentration in plasma and cerebrospinal fluid.

Get recall alerts

Free email alert whenever Roche Diagnostics Corporation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Roche Diagnostics Corporation